Vascular Compartment Volume Estimation via Combined PET MRI
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The estimation of vascular compartment volume (VB) from dynamic Positron Emission Tomography (PET) data is unreliable due to noise in early time frames and lacks robustness when using PET alone, while relying on MRI or atlases does not account for patient-specific variations and disease-induced changes in blood vessel formation.
Innovation Solution
A combined PET/MRI system is used to simultaneously acquire images, where a PET scan contrast agent and an MRI contrast agent are administered, allowing the calculation of VB from MRI data and subsequent pharmacokinetic analysis based on this value and PET images, leveraging the reduced noise and finer resolution of MRI for more accurate VB estimation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If VB is estimated from dynamic PET data using early time frames, then the estimation can be obtained, but the reliability is poor due to noise in early time frames
Solution Approach 1:
The patent introduces MRI as an intermediary modality to estimate VB. Instead of directly estimating VB from noisy PET data, the method uses MRI to obtain VB estimation, which then serves as a reliable input for PET pharmacokinetic modeling. This intermediary approach leverages MRI's superior signal-to-noise ratio and spatial resolution to provide accurate VB values without the noise problems inherent in early PET time frames.
Solution Approach 2:
The patent performs VB estimation using MRI before conducting the PET pharmacokinetic analysis. By obtaining the VB value in advance from MRI data, the method eliminates the need to rely on noisy early PET time frames for VB estimation. This preliminary action ensures that the VB parameter is accurately determined before it is used in the PET modeling process, improving overall reliability.
2Ease of operation
If VB is pre-estimated from atlases and average anatomy information, then the process is simplified, but the robustness is reduced due to inability to account for patient-specific variations
Solution Approach 1:
The patent transitions from using average anatomy information (global quality) to using patient-specific MRI data (local quality). By acquiring and processing individual patient MRI scans, the method captures unique anatomical variations, vascular characteristics, and pathophysiological conditions specific to each patient. This local approach ensures that VB estimation is tailored to the individual patient's actual vascular compartment structure rather than relying on population averages.
Solution Approach 2:
The patent changes the input parameter from static atlas-based average anatomy to dynamic patient-specific MRI data. This parameter change allows the VB estimation to adapt to individual patient characteristics including anatomical variations, disease states, and vascular changes. The method processes actual patient MRI images to extract VB values, transforming the estimation from a generic population-based approach to a personalized patient-specific approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more reliable estimation of VB and rate constants by reducing noise and accounting for individual anatomical variations, enhancing the accuracy of pharmacokinetic modeling in PET imaging.
Implementation Method 1
A radioactive (positron emitting) tracer isotope is incorporated in a metabolically active molecule... which detects and records the gamma type radiation resulting from a collision between an emitted positron and an electron in the surrounding matter
Implementation Method 2
simultaneously performing a PET scan and an MRI scan on the subject to generate PET scan images and corresponding data from the MRI scan
Data Source
AI summary
A method is described for acquiring and analysing the data produced by Positron Emission Tomography (PET), which method provides for an accurate estimation of vascular compartment volume, VB. An MRI scan and the PET scan is performed simultaneously and the results of the former is used to derive a value for VB. The value so derived is then used in pharmacokinetic modelling along with the results of the functional scan.